PID
Invesco International Dividend Achievers ETF · NAS
- Category Equity
- Expense Ratio 0.53%
- Listing Date Sep 15, 2005
- Volume 129,294.0
- Market Cap (AUM) $841.92M
Performance
-3.82%
1W
-4.67%
1M
-3.52%
3M
-0.15%
6M
-2.3%
YTD
+2.64%
1Y
Top Holdings
-
Name
Symbol%Assets
- Atlantica Sustainable Infrastructure plcAY4.95%
- Brookfield Renewable Partners LPBEP.UT4.63%
- PLDT, Inc. Sponsored ADRPHI4.27%
- Enbridge Inc.ENB4.16%
- British American Tobacco PLC Sponsored ADRBTI4.14%
- Canadian Imperial Bank of CommerceCM4.07%
- TC Energy CorporationTRP3.99%
- Brookfield Infrastructure Partners L.P.BIP3.89%
- BCE Inc.BCE3.71%
- TELUS CorporationT3.67%
Technical Analysis of PID 2024-05-31
Overview:
In the last 5 trading days, PID stock has shown mixed signals across various technical indicators. The stock price has fluctuated within a narrow range, indicating indecision in the market. We will analyze the trend, momentum, volatility, and volume indicators to determine the possible future stock price movement.
Trend Indicators:
- Mo...
Recent News & Updates
- 2017-03-26 22:37
Sandoz: Novartiss Generics Business in 2016(Marketrealist)
- 2017-03-26 21:08
Novartiss Innovative Medicines Segment in 2016(Marketrealist)
- 2017-02-20 21:36
What Happened to Sanofis Valuation after 4Q16?(Marketrealist)
- 2017-02-19 18:37
This Keeps Driving Sanofis Growth(Marketrealist)
- 2017-02-15 18:35
GlaxoSmithKlines Consumer Healthcare Reports Growth in 4Q16(Yahoo Finance)
- 2017-02-14 21:36
GlaxoSmithKlines Vaccines Business Reported Growth in 4Q16(Marketrealist)
- 2017-02-14 00:35
4Q16 Performance of GlaxoSmithKlines Business Segments(Marketrealist)
- 2017-02-01 03:35
Novartiss Innovative Medicines Segment in 4Q16(Marketrealist)
- 2017-01-29 21:36
PotashCorp in 4Q16: Nitrogen Prices Added Salt to the Wound(Marketrealist)
- 2017-01-22 20:07
Novartiss 4Q16 Estimates: Innovative Medicines Segment(Marketrealist)
- 2017-01-16 20:06
How Did Novartiss Generics Business Perform in 3Q16?(Marketrealist)
- 2016-12-29 20:07
How GlaxoSmithKlines Pharmaceuticals Segment Has Performed(Marketrealist)
- 2016-12-13 20:30
- 2016-12-12 22:05
4 High Dividend ETFs Under $20(Yahoo Finance)
- 2016-11-23 03:01
PowerShares Announces Listing Transfer for 27 ETFs(Yahoo Finance)
- 2016-11-16 22:04
How Sandoz Performed for Novartis in 3Q16(Marketrealist)
- 2016-11-02 22:04
How Tresiba Helps Novo Achieve Its Growth Targets(Marketrealist)
- 2016-11-02 20:04
Victoza Dominates Global GLP-1 Class(Marketrealist)
- 2016-11-01 23:04
- 2016-11-01 06:04
US Still the Largest Market for Novo Nordisk(Marketrealist)
- 2016-10-31 20:04
Why Did PotashCorps Nitrogen Prices Fall in 3Q16?(Marketrealist)
- 2016-10-24 22:52
How Much Is the Return Opportunity for Novo Nordisk in 3Q16?(Marketrealist)
- 2016-10-23 23:04
Novartiss 3Q16 Estimates: Will Alcon Recover Its Growth?(Marketrealist)
- 2016-10-23 20:05
Novartiss 3Q16 Estimates: Innovative Medicines Segment(Marketrealist)
- 2016-10-19 21:44
5 Best Smart Beta ETFs That Pay Dividends (PID, ICF)(Investopedia)
- 2016-10-07 01:16
Is the Dividend ETF Bull Run Over?(Yahoo Finance)
- 2016-10-05 21:00
International Dividend ETFs Remain Solid Ideas(Yahoo Finance)
- 2016-10-02 22:04
- 2016-09-30 06:04
- 2016-09-29 05:04
Novo Nordisk Is Focusing on These Strategic Areas in 2016(Marketrealist)
- 2016-09-27 23:04
Tevas Share of the US Generics Market Could Boost Its Stock(Marketrealist)
- 2016-09-25 23:05
Winning? We Review How Teva Dominates Generic Drug Space(Marketrealist)
- 2016-09-14 23:04
- 2016-09-14 20:04
- 2016-09-12 23:04
- 2016-09-12 22:04
GlaxoSmithKline Giving a Shot to Its Vaccines Business(Marketrealist)
- 2016-09-11 23:04
- 2016-09-08 00:27
5 Undervalued ETFs for Dividend Lovers(Yahoo Finance)
- 2016-09-07 23:18
Analyzing Sanofis Asset Swap Deal with Boehringer Ingelheim(Marketrealist)
- 2016-08-21 23:04
How Merial Contributes to Sanofis Growth(Marketrealist)